TP53 and myelodysplastic syndrome: Li-Fraumeni syndrome is caused by a pathogenic germline mutation in TP53 and is linked to a markedly increased risk of various solid tumors—such as those of the breast, pancreas, central nervous system, and sarcomas—as well as blood malignancies like MDS, AML, and ALL.